2-取代吲哚的染料敏化光氧化反应

2-苯基吲哚 (1a) 在甲醇中的染料敏化光氧化反应给出2-苯基-2-(2'-苯基-3'-吲哚基)二氢吲哚-3-酮 (2a) 和2-甲氧基-2-苯基二氢吲哚-3-酮 (4a), 相应N-甲基取代产物由1-甲基-2-苯基吲哚 (1b) 的类似反应获得。发现反应产物分布随吲哚 (1) 的浓度和介质酸度的变化而变化。对反应机理进行了推测, 其中当1a的反应在乙腈中进行时, 分离到了相应的反应中间体: 2-苯基-3H-吲哚-3-酮 (3a)。     

3-烷氧基-3-烷基异吲哚啉-1-酮的合成

为探索3-亚烷基异吲哚啉-1-酮在有机合成中的应用潜力，构建新型的异吲哚啉-1-酮类化合物，本文以3-亚烷基异吲哚啉-1-酮和醇为原料，在三氯硅烷与路易斯碱催化剂作用下发生加成反应，得到一系列3-烷氧基-3-烷基异吲哚啉-1-酮类化合物，并初步尝试了以手性路易斯碱催化该反应。综上，本文建立了一种新型异吲哚啉-1-酮类化合物的合成方法，该方法条件具有温和、操作便捷、底物适用范围广和收率普遍较高的特点。     

5-取代吲哚-2-酮的合成

4-取代苯胺依次与水合氯醛及盐酸羟胺反应制得4-取代异亚硝基乙酰苯胺(2a～2e);2在浓硫酸作用下环合制得5-取代靛红(3a～3e);3通过改进的Wolff-Kishner-黄鸣龙反应合成了重要的药物中间体——5-取代吲哚-2-酮(5a～5e);5a通过硝化制得5-硝基吲哚-2-酮(5f);5f被还原制得5-氨基吲哚-2-酮(5g)。其结构经1H NMR和MS确证。     

3-氨基-2-吲哚酮合成方法的改进

以苯胺为原料,通过传统方法合成靛红,靛红与盐酸羟胺反应生成3-羟基亚氨基-2-吲哚酮,再通过钯碳加氢还原生成3-氨基-2-吲哚酮。合成中,采用钯碳加氢的还原方式,产物收率提高(收率82.76%,较文献提高了11.8%),后处理更简单。该方法可操作性高、成本低、产生三废少,是一条适合大规模生产3-氨基-2-吲哚酮的新合成工艺路线。     

无溶剂、无催化剂条件下5-[(3-吲哚基)-芳甲基]-2,2-二甲基-l,3-二氧六环-4,6-二酮的合成

在无溶剂和催化剂条件下，由芳香醛、吲哚、丙二酸亚异丙酯的三组分缩合反 应，制备了5．[(3-吲哚基)-芳甲基]-2，2-二甲基-1，3-二氧六环-4，6-二酮，产 率为70％～85％，产物结构经～1H NMR，IR确证．     

2-吗啉基-1-丙基-1H-吲哚-3-取代酰腙类化合物的合成及抑菌活性

以2-吲哚酮为先导化合物,设计合成一系列2-吗啉基-1-丙基-1H-吲哚-3-取代酰腙类化合物.目标化合物结构经核磁共振波谱(1H NMR和13C NMR)和高分辨质谱仪(HRMS)进行确证.采用浊度法测试了目标化合物的离体抑菌活性,抑菌活性测试结果表明:目标化合物对柑橘溃疡病菌(Xanthomonas axonopodis pv.Citri,X.citri)、烟草青枯病菌(Ralstonia.Solanacearum,R.solanacearum)和水稻白叶枯病菌(Xanthomonas oryzae pv.Oryzae,X.oryzae)均表现出一定的抑制活性.化合物2-氰基-N'-((2-吗啉基-1-丙基-1H-吲哚-3-基)亚甲基)乙酰肼(12a)、4-氯-N'-((2-吗啉基-1-丙基-1H-吲哚-3-基)亚甲基)苯甲酰肼(12c)、4-氟-N'-((2-吗啉基-1-丙基-1H-吲哚-3-基)亚甲基)苯甲酰肼(12f)、N'-((2-吗啉基-1-丙基-1H-吲哚-3-基)亚甲基)-4-硝基苯甲酰肼(12k)和N'-((2-吗啉基-1-丙基-1H-吲哚-3-基)亚甲基)异烟肼(12m)表现出较好的抑制活性;化合物12a、12c、12f、12k和12m对水稻白叶枯病菌的EC50为73.79、61.94、59.70、36.72和82.79μg/m L,抑制活性优于对照药叶枯唑和噻菌铜(EC50分别为92.4、120.22μg/m L).     

“一锅串联法”合成2-[(E)-2-2-氯-1-甲基-3-吲哚基)乙烯基]喹啉-3-羧酸(英文)

设计了以2-(溴甲基)喹啉-3-甲酸乙酯(4)与2-氯-1-甲基-3-吲哚醛(5)为起始化合物,通过简便有效的"一锅法"反应,首次将吲哚环引入2-苯乙烯基喹啉骨架模型,从而得到一新颖结构的双杂环化合物,即(E)-2-(2-(2-氯-1-甲基-1H-3-吲哚基)乙烯基)喹啉-3-羧酸(3),其结构通过波谱数据和元素分析得以证实。     

靛红亚胺参与构建手性3-氨基-2-吲哚酮骨架的研究进展

手性3-氨基-2-吲哚酮骨架广泛存在于许多药物分子以及天然产物中,具有较高的药用价值。 靛红亚胺参与的不对称反应是合成手性3-氨基-2-吲哚酮衍生物的直接途径。 本文围绕着不对称aza-Henry反应、不对称环化反应及其他不对称反应3个方面,综述了靛红亚胺参与构建手性3-氨基-2-吲哚酮衍生物的研究进展并进行了展望。     

3-仲氨基氧杂环丁烷-3-腈衍生物的合成

以仲胺、氧杂环丁-3-酮和三甲基氰硅烷为原料,无水甲醇为溶剂,无需催化剂,一步反应合成目标化合物3-仲氨基氧杂环丁烷-3-腈衍生物（1a~1d）,产物结构经1H NMR和ESI-MS表征。并以异吲哚啉、氧杂环丁-3-酮和三甲基氰硅烷的反应为模型反应,考察影响产物1a收率的主要因素,确定最佳反应条件为：物料摩尔比为n（异吲哚啉）: n（氧杂环丁-3-酮）: n（三甲基氰硅烷）= 2.0 : 1 : 2.5;反应溶剂为无水甲醇,在65 ℃反应6 h。在最佳反应条件下,化合物1a收率78.3 %。对于目标化合物的应用进行了研究,发现化合物1a与苯基溴化镁在四氢呋喃溶剂中,室温反应5 h,得到2-(3-苯基氧杂环丁烷-3-基)异吲哚啉（4）和 [3-(异吲哚啉-2-基) 氧杂环丁烷-3-基](苯基)甲酮（5）,收率分别为40.1 %和31.5 %。     

3-氨基-2-吲哚酮的新合成方法

以苯胺为原料,通过传统方法合成靛红。靛红与盐酸羟胺反应生成3-羟基亚氨基-2-吲哚酮,再通过钯碳加氢还原生成3-氨基-2-吲哚酮。合成中,采用钯碳加氢的还原方式,产物收率提高（收率82.76%,较文献提高了11.8%）,后处理更简单,而且该方法可操作性高,成本低,产生三废少,是一条适合大规模生产3-氨基-2-吲哚酮的新合成工艺路线。     

2-芳基吲哚的敏化光氧化偶合反应

本文研究了十七种2-芳基吲哚(1a-1q)在甲醇-乙酸介质中的亚甲基蓝(MB)敏化光氧化反应, 发现有十五种吲哚(1a-1o)以85%-95%的产率给出2,2'-二芳基-[2,3'-联-1H-吲哚]-3(2H)-酮(2a-2o), 而2-(4-硝基苯基]吲哚(1p)和2-联苯基吲哚(1q)则分别生成2-甲氧基-2-(4-硝基苯基)-1,2-二氢-3H-吲哚-3-酮(7p)和2-联苯基-4H-3,1-苯并恶嗪-4-酮(11q), 其中7p在分离过程中失去甲醇分子给出2-(4-硝基苯基)-3H-吲哚-3-酮(10p)。     

Synthesis of Some Heterocyclic Compounds from 1H‐Indole‐2,3‐Dione: A Direct One‐Pot Synthesis of Spiro Indolone Derivatives

Some spiro indolone derivatives 5_a,b and 6 were synthesized through one‐pot synthesis via the ternary condensation of 1H‐indole‐2,3‐dione 1 , 3‐methyl‐1‐phenyl‐2‐pyrazolin‐5‐one 2 and active methylenes, namely malononitrile, ethyl cyanoacetate 4_a,b and pyrazolone 2 , respectively. The same derivatives can be obtained via other methods, through reactions of 3‐[3‐methyl‐5‐oxo‐1‐phenyl‐1,5‐dihydro‐pyrazol‐(4Z)‐ylidene]‐1,3‐dihydro‐indol‐2‐one 3 with the corresponding active methylenes. Reaction of 3 with amines and with ethyl vinyl ether was studied.     

Reaction of 3‐Hydroxyquinoline‐2,4‐diones with Isocyanates and Thermally Induced Transformation of the Reaction Products

3‐Hydroxyquinoline‐2,4‐diones 1 react with isocyanates to give novel 1,2,3,4‐tetrahydro‐2,4‐dioxoquinolin‐3‐yl (alkyl/aryl)carbamates 2 and/or 1,9b‐dihydro‐9b‐hydroxyoxazolo[5,4‐c]quinoline‐2,4(3aH,5H)‐diones 3 . Both of these compounds are converted, by boiling in cyclohexylbenzene solution in the presence of Ph₃P or 4‐(dimethylamino)pyridine, to give 3‐(acyloxy)‐1,3‐dihydro‐2H‐indol‐2‐ones 8 . All compounds were characterized by IR, and ¹H‐ and ¹³C‐NMR spectroscopy, as well as by EI mass spectrometry.     

1-甲基-2-苯基吲哚的琥红敏化单重态氧反应

1-甲基-2-苯基吲哚(1)在甲醇中的琥红(RB)敏化单重态氧反应生成1-甲基-2-甲基氧-2-苯基-1, 2-二氢-3H-吲哚-3-酮(4)和1-甲基-2-羟基-2-苯基-1, 2-二氢-3H-吲哚-3-酮(6), 后者在强碱性介质下发生苯乙醇酸型重排生成1-甲基-3-羟基-3-苯基氧化吲哚(14)。研究了6的溶剂分解反应以及外加碱对光氧化反应的影响。探讨了光氧化产物的形成途径。结果表明: 4系两性离子中间体2的溶剂捕获、脱水产物, 而6则系二氧杂环丁烷中间体7的裂解、抽氢产物。     

Asymmetric Proline‐Catalyzed Addition of Aldehydes to 3H‐Indol‐3‐ones: Enantioselective Synthesis of 2,3‐Dihydro‐1H‐indol‐3‐ones with Quaternary Stereogenic Centers

The proline‐catalyzed addition of various aliphatic aldehydes to sterically hindered 2‐aryl‐substituted 3H‐indol‐3‐ones affords 2,2‐disubstituted 2,3‐dihydro‐1H‐indol‐3‐one derivatives with excellent enantioselectivities. In addition, the synthesis of a chiral derivative, (S)‐2‐(2‐bromophenyl)‐2,3‐dihydro‐2‐(2‐hydroxyethyl)‐1H‐indol‐3‐one, which can be used as an intermediate for the preparation of the natural product hinckdentine A was accomplished with a high level of enantioselectivity.     

Catalytic Enantioselective Synthesis of a 3‐Aryl‐3‐benzyloxindole (=3‐Aryl‐3‐benzyl‐1,3‐dihydro‐2H‐indol‐2‐one) Exhibiting Antitumor Activity

A palladium‐catalyzed intramolecular α‐arylation of an amide in the presence of a bulky chiral N‐heterocyclic carbene ligand is the key step in the first catalytic synthesis of (3R)‐6‐chloro‐3‐(3‐chlorobenzyl)‐1,3‐dihydro‐3‐(3‐methoxyphenyl)‐2H‐indol‐2‐one ((R)‐ 5 ). This oxindole, in racemic form, had been shown previously to be an anticancer agent. (R)‐ 5 was obtained with an overall yield of 45% and with 96% enantioselectivity.     

The Synthesis of New Heterocycles Using 2‐(4‐Chloro‐1,3‐dihydro‐3,3,7‐trimethyl‐2H‐indol‐2‐ylidene) Propanedial

4‐Chloro‐2,3,3,7‐tetramethyl‐3H‐indole (an indolenine) was produced by the reaction of 5‐chloro‐2‐methylphenylhydrazine hydrochloride with 3‐methylbutan‐2‐one via Fischer reaction. Exposure of the indolenine to the Vilsmeier reagent at 50°C produced a β‐diformyl compound, 2‐(4‐chloro‐1,3‐dihydro‐3,3,7‐trimethyl‐2H‐indol‐2‐ylidene)propanedial. This dialdehyde was reacted with arylhydrazines, acetamidinium chloride, urea, thiourea, guanidinium chloride, and cyanoacetamide to give various 5‐membered and 6‐membered heterocyclic products, each carrying a 4‐chloro‐3,3,7‐trimethyl‐3H‐indol‐2‐yl unit as a substituent, in excellent yields.     

On the Reactions of Furan‐2,3‐diones with Oxindole (=1,3‐Dihydro‐2H‐indol‐2‐one) and Lawesson Reagent. Synthesis of New 1,3‐Dihydro‐2H‐indol‐2‐ones,Bis‐furanones,and Bis‐pyrrolones

Lactone analogues of 3‐substituted oxindoles (=1,3‐dihydro‐2H‐indol‐2‐ones) and nonbenzoid oxa‐analogous isoindigoid or nonbenzoid isoindigoid dyes were prepared by the reactions of furan‐2,3‐diones with oxindole and Lawesson reagent (Schemes 1 and 3), respectively. So, new derivatives of 2‐oxobutanoic acid, bis‐furanone, and bis‐pyrrolone, which are potentially biologically active compounds, were synthesized for the first time.     

Diastereoselective Synthesis of (Z)‐6‐(2‐Oxo‐1,2‐dihydro‐3H‐indol‐3‐ylidene)‐3,3a,9,9a‐tetrahydroimidazo[4,5‐e]thiazolo[3,2‐b]‐1,2,4‐triazin‐2,7(1H,6H)‐diones

Two efficient and diastereoselective procedures for the synthesis of (Z)‐6‐(2‐oxo‐1,2‐dihydro‐3H‐indol‐3‐ylidene)‐3,3a,9,9a‐tetrahydroimidazo[4,5‐e]thiazolo[3,2‐b]‐1,2,4‐triazin‐2,7(1H,6H)‐diones by aldol‐crotonic condensation of 1,3‐dimethyl‐3a,9a‐diphenyl‐3,3a,9,9a‐tetrahydroimidazo[4,5‐e]thiazolo[3,2‐b]‐1,2,4‐triazin‐2,7(1H,6H)‐dione with isatins under acidic or basic catalysis are reported. Isomerization in (Z)‐7‐(1‐allyl‐2‐oxo‐1,2‐dihydro‐3H‐indol‐3‐ylidene)‐1,3‐dimethyl‐3a,9a‐diphenyl‐1,3a,4,9a‐tetrahydroimidazo[4,5‐e]thiazolo[2,3‐c]‐1,2,4‐triazin‐2,8(3H,7H)‐dione was observed under basic conditions.     

[2,3′-联-1H-吲哚]-3(2H)-酮类化合物的单重态氧反应

[2,3’-联-1H-吲哚]-3(2H)-酮衍生物(1a～1c)在甲醇中的单重态氧反应给出溶剂捕捉产物4,后者在分离过程中脱去甲醇分子生成5。考察了标题化合物分子中二氢吲哚酮结构单元以及吲哚结构单元在单重态氧反应中的作用。并探讨了反应机理。